Click here to search courses using NAPNAP's previous Course Catalog layout.

Title
Category
Credits
Event date
Cost
  • Primary Care
  • Acute Care
  • Pharmacology CE
  • Contact hours
$20.00
1.00 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. This presentation will focus on medications commonly prescribed for dermatology conditions such as atopic dermatitis, psoriasis, skin infections and infestations, acne, molluscum and warts. Learners will gain a knowledge of common treatments and applicable clinical judgement skills to choose optimal medication treatment options for our patients.
  • Primary Care
  • Acute Care
  • Pharmacology CE
  • Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. An extensive review will provide the participant with up-to-date information pharmacological management of common respiratory illnesses in children.
  • Primary Care
  • Acute Care
  • Infectious Disease
  • Pharmacology CE
  • Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. Current information from CDC will be reviewed. Most current information about vaccine safety will also be covered.
  • Primary Care
  • Acute Care
  • Pharmacology CE
  • Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. An extensive review will provide an up‐to‐date information on current recommendations for use of GI drugs in the pharmacological management of common GI pathologies in children.
  • Primary Care
  • Acute Care
  • Pharmacology CE
  • Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. This module will introduce nutraceuticals and review common pediatric uses for nutraceuticals.
  • Primary Care
  • Acute Care
  • Infectious Disease
  • Pharmacology CE
  • Contact hours
$25.00
1.25 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $12 for NAPNAP Members. For non- members, this continuing education activity rate is $25. This presentation will discuss prescribing for pediatric patients in light of spotlights on inappropriate antibiotic prescribing. A rapid review of current guidelines for treating pediatric infectious diseases will frame a discussion on how to incorporate guidelines into daily practice. Local and national resistance patterns will be discussed, as well as adverse effects of antibiotics including rising resistance and C. difficile rates.
  • Primary Care
  • Acute Care
  • Pharmacology CE
  • Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. An extensive review will provide the participant with up-to-date information pharmacological management of common respiratory illnesses in children.
  • Mental Health
  • Pharmacology CE
  • Psychopharmacology CE
  • Contact hours
$15.00
0.75 NAPNAP contact hour, of which0.5 is Pharmacology, 0.5 Psychopharmacology and 0.25 is Controlled substance. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $7.5 for NAPNAP Members. For non- members, this continuing education activity rate is $15. The purpose of this session is to provide the pediatric-focused APRN with an introduction to the use and effects of cannabis on children and youth. The discussion includes a conversation about the current cannabis laws, the physiologic effects of cannabis, the evidence for cannabis use in pediatrics and guideline for facilitating discussions with families who have interest in using cannabis for their children. This session is appropriate for providers from all patient care settings and for the novice to seasoned APRN.
  • Mental Health
  • Pharmacology CE
  • Psychopharmacology CE
  • Contact hours
$20.00
1.0 NAPNAP contact hour, of which 1.0 is Pharmacology and 1.0 Psychopharmacology. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. An extensive review will provide the participant with up-to-date information about commonly used antidepressants and atypical antipsychotics.
  • Mental Health
  • Pharmacology CE
  • Psychopharmacology CE
  • Contact hours
$25.00
1.25 NAPNAP contact hour, of which 0.5 is Pharmacology and 0.5 Psychopharmacology. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $12.5 for NAPNAP Members. For non- members, this continuing education activity rate is $25. This session will focus on the increased prevalence of anxiety and depression in children and adolescents in our post-COVID society. The lack of available child psychology and psychiatry services has increased the role of pediatric-focused NPs in providing evidence-based treatment of young patients with these diagnoses throughout the pandemic. Using case-based scenarios and interactive technology, participants will discuss factors impacting symptom presentation and review pharmacologic and non-pharmacologic treatment strategies. Innovative, COVID-friendly mental health resources and coping strategies for children, adolescents and their families will be presented.

Pages